Financhill
Back

Fate Therapeutics Stock Predictions

Fate Therapeutics Stock Forecast

  • Over the next 52 weeks, Fate Therapeutics has on average historically risen by 44.7% based on the past 10 years of stock performance.
  • Fate Therapeutics has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Fate Therapeutics Stock Undervalued?
    The current Fate Therapeutics [FATE] share price is $7.34. The Score for FATE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • FATE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Fate Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Fate Therapeutics has on average historically risen by 44.7% based on the past 10 years of stock performance.

Fate Therapeutics Stock Rating

Sell
43
Fate Therapeutics (FATE) is a Sell

Is Fate Therapeutics overpriced?

  • Fate Therapeutics has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Fate Therapeutics Stock Price History

Is FATE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FATE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
fatetherapeutics.com

52-Week Data

52-Week High:
8.83
52-Week Low:
1.63

Prediction Charts

Market Cap:
728.4M
Price in USD:
7.34
Volume:
2.71M
Beta:
1.75

Technical Analysis

SMA50:
6.63
SMA100:
4.82
SMA200:
4.02
52-Wk Change:
39.28%

Stock Predictions

  • Is Fate Therapeutics stock public?
    Yes, Fate Therapeutics is a publicly traded company.
  • What is the Fate Therapeutics stock quote today?
    The Fate Therapeutics stock price is 7.34 USD today.
  • How to buy Fate Therapeutics stock online?
    You can buy Fate Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-11 8.15 7.89 8.44 7.86
Mar-12 7.83 7.66 8.27 7.65
Mar-13 7.60 7.63 7.98 7.40
Mar-14 7.62 7.23 7.67 6.91
Mar-15 7.24 7.49 7.70 7.21
Mar-18 7.49 7.03 7.50 6.95
Mar-19 6.83 7.00 7.28 6.80
Mar-20 6.95 7.44 7.66 6.78
Mar-21 7.51 7.43 7.70 7.19
Mar-22 7.47 6.61 7.59 6.61
Mar-25 6.58 6.87 7.01 6.54
Mar-26 7.03 6.86 7.13 6.68
Mar-27 6.97 7.34 7.37 6.77
Mar-28 7.27 7.34 7.65 7.23

Fate Therapeutics Earnings

Fate Therapeutics Earnings Report: Per Share Fate Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Fate Therapeutics Forecast Revenue Growth

Fate Therapeutics Stock Analysis: Historical quarterly revenues per share for Fate Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.15 per share, and an increase next year of $0.20 per share.

* Fate Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.